Business · 19/05/1997

FDA Publishes Guideline on Impurities in New Drug Products Under ICH Harmonisation

The FDA has released a new guideline on impurities in new drug products, developed in collaboration with the International Conference on Harmonisation, providing guidance for pharmaceutical companies on the content and qualification of impurities in new drug substances not previously approved in a region or member state.